Haemonetics (HAE) Interest & Investment Income (2009 - 2011)

Haemonetics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $106000.0 for Q3 2011.

• On a quarterly basis, Interest & Investment Income rose 3.92% year-over-year to $106000.0 in Q3 2011; TTM through Jul 2011 was $773000.0, a 120.23% increase from a year earlier, with the FY2011 full-year figure at $384000.0, down 3.76% from the prior year.
• Interest & Investment Income advanced to $106000.0 in Q3 2011 per HAE's latest filing, from $83000.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $493000.0 in Q4 2010 and bottomed at $56000.0 in Q4 2009.
• The 3-year median for Interest & Investment Income is $102000.0 (2010), against an average of $142333.3.
• Biggest YoY gain for Interest & Investment Income was 378.64% in 2010; the steepest drop was 35.03% in 2010.
• Year by year, Interest & Investment Income stood at $56000.0 in 2009, then surged by 780.36% to $493000.0 in 2010, then plunged by 78.5% to $106000.0 in 2011.
• Per Business Quant, the three latest HAE Interest & Investment Income figures stand at $106000.0 (Q3 2011), $83000.0 (Q2 2011), and $91000.0 (Q1 2011).